The global human microbiome therapeutics market, valued at USD 1.01 billion in 2024, is poised for significant expansion, projected to grow at a CAGR of 22.80% from 2025 to 2034. This growth is driven by increasing recognition of the microbiome's role in health, advancements in next-generation sequencing technologies, and rising prevalence of microbiome-related diseases. Regionally, North...
0 Commentarios
0 Acciones
908 Views
0 Vista previa
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek